Mineralocorticoid receptor isoforms

Current Opinion in Endocrinology and Diabetes

Volumn 5, Issue 3, 1998, Pages 183-188

  Zennaro, Maria Christina ^a   Lombès, Marc ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MINERALOCORTICOID RECEPTOR;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL TISSUE; HORMONE RECEPTOR INTERACTION; MOLECULAR CLONING; NONHUMAN; PATHOPHYSIOLOGY; PROMOTER REGION; RAT; RECEPTOR BINDING; REVIEW; TRANSLATION INITIATION;

EID: 0031861517     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-199806000-00006     Document Type: Review

References (60)

1. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans R: The nuclear receptor superfamily: the second decade. Cell 1995, 83:835-839.
2. Evans RM: The steroid and thyroid hormone receptor superfamily. Science 1988, 240:889-895.
3. Laudet V, Hanni C, Coll J, Catzeflis F, Stehelin D: Evolution of the nuclear receptor gene superfamily. EMBO J 1992, 11:1003-1013.
4. Umesono K, Evans RM: Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell 1989, 57:1139-1146.
5. Dahlman-Wright K, Wright A, Gustafsson J, Carlstedt-Duke J: Interaction of the glucocorticoid receptor DNA-binding domain with DNA as a dimer is mediated by a short segment of five amino acids. J Biol Chem 1991, 266:3107-3112.
6. Luisi BF, Schwabe JWR, Freedman LP: The steroid/nuclear receptors: from three-dimensional structure to complex function. Vitam Hormon 1994, 49:1-47.
7. Giguere V, Hollenberg SM, Rosenfeld MG, Evans RM: Functional domains of the human glucocorticoid receptor. Cell 1986, 46:645-652.
8. Picard D, Yamamoto DR: Two signals mediate hormone-dependent nuclear localization of the GR. EMBO J 1987, 6:3333-3340.
9. Couette B, Fagart J, Jalaguier S, Lombès M, Souque A, Rafestin-Oblin ME: Ligand-induced conformational change in the human mineralocorticoid receptor occurs within its hetero-oligomeric structure. Biochem J 1996, 315:421-427.
10. Bruner KL, Derfoul A, Robertson NM, Guerriero G, Fernandez-Alnemri T, Alnemri ES, Litwack G: The unliganded mineralocorticoid receptor is associated with heat shock proteins 70 and 90 and the immunophilin FKBP-52. Recept Signal Transduct 1997, 7:85-98.
11. Bamberger CM, Wald M, Bamberger A-M, Schulte H: Inhibition of mineralocorticoid and glucocorticoid receptor function by the heat shock protein 90-binding agent geldanamycin. Mol Cell Endocrinol 1997, 131:233-240.
12. Tsai M-J, O'Malley B: Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 1994, 63:451-486.
13. Lombès M, Binart N, Oblin M-E, Joulin V, Baulieu EE: Characterization of the interaction of the human mineralocorticoid receptor with hormone responsive elements. Biochem J 1993, 292:577-583.
14. Trapp T, Rupprecht R, Castrèn M, Reul JMHM, Holsboer F: Heterodimerization between mineralocorticoid and glucocorticoid receptor: a new principle of glucocorticoid action in the CNS. Neuron 1994, 13:1457-1462.
15. Liu W, Wang J, Sauter NK, Pearce D: Steroid receptor heterodimerization demonstrated in vitro and in vivo. Proc Natl Acad Sci U S A 1995, 92:12480-12484.
16. Zennaro M-C, Le Menuet D, Lombès M: Characterization of the human mineralocorticoid receptor gene 5′-regulatory region: evidence for differential hormonal regulation of two alternative promoters via non-classical mechanisms. Mol Endocrinol 1996, 10:1549-1560.
17. Verrey F: Transcriptional control of sodium transport in tight epithelia by adrenal steroids. J Membr Biol 1995, 144:93-110.
18. Joels M, deKloet ER: Corticosteroid hormones: endocrine messengers in the brain. NIPS 1995, 10:71-76.
19. Brilla CG, Pick R, Tan LB, Janicli JS, Weber KT: Remodeling of the rat right and left ventricle in experimental hypertension. Circ Res 1990, 67:1355-1364.
20. Young M, Fullerton M, Dilley R, Funder JW: Mineralocorticoids, hypertension and cardiac fibrosis. J Clin Invest 1994, 93:2578-2583.
21. Armanini D, Strasser T, Weber PC: Characterization of aldosterone binding sites in circulating human mononuclear leukocytes. Am J Physiol 1985, 248:E288-E290.
22. Kenouch S, Lombès M, Delahaye F, Eugène E, Bonvalet JP, Farman N: Human skin as target for aldosterone: coexpression of mineralocorticoid receptors and 11β-hydroxysteroid dehydrogenase. J Clin Endocrinol Metab 1994, 79:1334-1341.
23. Kern RC, Foster JD, Pitovski DZ: Mineralocorticoid (type I) receptors in the olfactory mucosa of the mammal: studies with [3H]aldosterone and the anti-mineralocorticoid spironolactone. Chem Senses 1997, 22:141-148.
24. Mirshahi M, Mirshahi A, Sedighian R, Hecquet C, Faure JP, Agarwal MK: Immunochemical demonstration of the mineralocorticoid receptor in ocular tissues. Neuroendocrinology 1997, 65:70-78.
25. Schwartz B, Wysocki A: Mineralocorticoid receptors in the rabbit irisciliary body. Ophthalmic Res 1997, 29:42-47.
26. Zennaro M-C, Le Menuet D, Viengchareun S, Walker F, Riquier D, Lombès M: Hibemoma development in transgenic mice identifies brown adipose tissue as a novel target of aldosterone action. J Clin Invest 1998, 101:1254-1260.
27. White PC, Mune T, Agarwal AK: 11β-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev 1997, 18:135-156.
28. Lombès M, Kenouch S, Souque A, Farman N, Rafestin-Oblin M-E: The mineralocorticoid receptor discriminates aldosterone from glucocorticoids independently of the 11β-hydroxysteroid dehydrogenase. Endocrinology 1994, 135:834-840.
29. Lim-Tio SS, Keightley MC, Fuller P: Determinants of specificity of transactivation by the mineralocorticoid or glucocorticoid receptor. Endocrinology 1997, 139:2537-2543.
30. Ueda K, Okamura N, Hirai M, Tanigawara Y, Saeki T, Kioka N, Komano T, Hori R: Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. J Biol Chem 1992, 267:24248-24252.
31. Kralli A, Bohen SP, Yamamoto KR: LEM1, and ATP-binding-cassette transporter, selectively modulates the biological potency of steroid hormones. Proc Natl Acad Sci U S A 1995, 92:4701-4705.
32. Schibler U, Sierra F: Alternative promoters in developmental gene expression. Annu Rev Genet 1987, 21:237-257.
33. Falvey E, Schibler U: How are regulators regulated? FASEB J 1991, 5:309-314.
34. Lopez JA: Developmental role of transcription factor isoforms generated by alternative splicing. Dev Biol 1995, 172:396-411.
35. Encio IJ, Detera-Wadleigh SD: The genomic structure of the human glucocorticoid receptor. J Biol Chem 1991, 266:7182-7188.
36. Bamberger CM, Bamberger AM, DeCastro M, Chrousos GP: Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 1995, 95:2435-2441.
37. Oakley RH, Webster JC, Sar M, Parker CR, Cidlowski JA: Expression and subcellular distribution of β-isoform of the human glucocorticoid receptor. Endocrinology 1997, 138:5028-5038.
38. Bamberger CM, Bamberger A-M, Wald M, Chrousos GP, Schulte H: Inhibition of mineralocorticoid activity by the β-isoform of the human glucocorticoid receptor. J Steroid Biochem Mol Biol 1997, 60:43-50.
39. Hecht K, Carlstedt-Duke J, Stierna P, Gustafsson J-A, Brönnegard M, Wikström A-C: Evidence that the β-isoform of the human glucocorticoid receptor does not act as a physiologically significant repressor. J Biol Chem 1997, 272:26659-26664.
40. Otto C, Reichardt HM, Schütz G: Absence of glucocorticoid receptor-β in mice. J Biol Chem 1997, 272:26665-26669.
41. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM: Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 1987, 236:268-275.
42. Patel PD, Sherman TG, Goldman DJ, Watson SJ: Molecular cloning of a mineralocorticoid receptor cDNA from rat hippocampus. Mol Endocrinol 1989, 3:1877-1885.
43. Patel PD, Kwak SP, Herman JP, Young EY, Akil H, Watson SJ: Functional heterogeneity of type I and type III corticosteroid receptor expression in rat hippocampus. In Stress and Reproduction/Serono Symposia, edn 86, Edited by Sheppard KE, Boublil JH, Funder JW. Melbourne: Raven Press; 1992:1-17.
44. Kwak SP, Patel PD, Thompson RC, Akil H, Watson SJ: 5′-Heterogeneity of the mineralocorticoid receptor messenger ribonucleic acid: differential expression and regulation of splice variants within rat hippocampus. Endocrinology 1993, 133:2344-2350.
45. Zennaro MC, Keightley MC, Kotelevtsev Y, Conway G, Soubrier F, Fuller PJ: Human mineralocorticoid receptor genomic structure and identification of expressed isoforms. J Biol Chem 1995, 270:21026-21020.
46. Listwak SJ, Gold PW, Whitfield HU Jr: The human mineralocorticoid receptor gene promoter: its structure and expression. J Steroid Biochem Mol Biol 1996, 58:495-506.
47. Bloem LJ, Guo C, Pratt JH: Identification of a splice variant of the rat and human mineralocorticoid receptor genes. J Steroid Biochem Mol Biol 1995, 55:159-162.
48. Ducouret B, Tujague M, Ashraf J, Mouchel N, Servel N, Valotaire Y, Thompson EB: Cloning of a teleost fish glucocorticoid receptor shows that it contains a deoxyribonucleic acid-binding domain different from that of mammals. Endocrinology 1995, 136:3774-3783.
49. Takeo J, Hata JI, Segawa C, Toyohara H, Yamashita S: Fish glucocorticoid receptor with splicing variants int he DNA binding domain. FASEB Lett 1996, 389:244-248.
50. Zennaro MC, Borensztein P, Jeunemaitre X, Armanini D, Soubrier F: No alteration in the primary structure of the mineralocorticoid receptor in a family with pseudohypoaldosteronism. J Clin Endocrinol Metab 1994, 79:32-38.
51. Komesaroff P, Verity K, Fuller PJ: Pseudohypoaldosteronism: molecular characterisation of the mineralocorticoid receptor. J Clin Endocrinol Metab 1994, 79:27-31.
52. Arai K, Tsigos C, Suzuki Y, Listwak S, Zachman K, Zangeneh F, Rapaport R, Chaoine J-P, Chrousos GP: No apparent mineralocorticoid receptor defect in a series of sporadic cases of pseudohypoaldosteronism. J Clin Endocrinol Metab 1995, 80:814-817.
53. Arai K, Naruse M, Zachman K, Demura H, Chrousos GP: Novel abnormalities in the amiloride-sensitive sodium channel in five sporadic cases with pseudohypoaldosteronism. Abstracts of the 79th Annual Meeting of the Endocrine Society 1997. Baltimore: The Endocrine Society; 1997:478.
54. Zennaro M-C, Farman N, Bonvalet J-P, Lombès M: Tissue-specific expression of α and β mRNA isoforms of the human mineralocorticoid receptor in normal and pathological states. J Clin Endocrinol Metab 1997, 82:1345-1352.
55. Hirata S, Koh T, Yamada-Mouri N, Kato J: The novel untranslated first exon "exon ON" of the rat estrogen receptor gene. Biochem Biophys Res Commun 1996, 225:649-854.
56. Erenburg I, Schachter B, Mira y Lopez R, Ossowski L: Loss of an estrogen receptor isoform (ERαΔS) in breast cancer and the consequences of its reexpression: Interference with estrogen-stimulated properties of malignant transformation. Mol Endocrinol 1997, 11:2004-2015.
57. Leygue E, Dotzlaw H, Watson PH, Murphy LC: Identification of novel exon-deleted progesterone receptor variant mRNAs in human breast tissue. Biochem Biophys Res Commun 1996, 228:63-68.
58. Chang SS, Grunder S, Hanukoglu A, Rosler A, Mathew PM, Hanukoglu I, Schild L, Lu Y, Shimkets RA, Nelson Williams C, et al.: Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat Genet 1996, 12:248-253.
59. Strautnieks SS, Thompson RJ, Gardner RM, Chung E: A novel splice-site mutation in the γ subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type I families. Nat Genet 1996, 13:248-250.
60. Chang SS, Müller J, Rösler A, Kemp S, Scott C, Rodriguez-Soriano J, Lifton R: Analysis of epithelial sodium channel subunits in pseudohypoaldosteronism type 1. J Am Soc Nephrol 1996, 7:1611.